Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies.

Science (New York, N.Y.)·2024

Same author

William A. Hinton (1883-1959): Diagnosing and Confronting Racism in the Medical Profession.

Journal of racial and ethnic health disparities·2021

Same author

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism.

PloS one·2021

Same author

Long-Term Engraftment and Fetal Globin Induction upon <i>BCL11A</i> Gene Editing in Bone-Marrow-Derived CD34<sup>+</sup> Hematopoietic Stem and Progenitor Cells.

Molecular therapy. Methods & clinical development·2017

Same author

Structural, super-resolution microscopy analysis of paraspeckle nuclear body organization.

The Journal of cell biology·2016

Same author

Corrigendum: Hallmarks of pluripotency.

Nature·2015

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Looking into the future of cell-based therapy.

M William Lensch¹, Jason A West

¹Division of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA. Mathew.Lensch@childrens.harvard.edu

Southern Medical Journal

|January 8, 2008

Summary

Scientists can now reprogram adult cells into embryonic-like stem cells using four genes. These induced pluripotent stem cells (iPS) hold promise for regenerative medicine and cellular therapies.

More Related Videos

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

Micro-scale Engineering for Cell Biology

Micro-scale Engineering for Cell Biology

Published on: October 1, 2007

Related Experiment Videos

Last Updated: Jul 8, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

Micro-scale Engineering for Cell Biology

Micro-scale Engineering for Cell Biology

Published on: October 1, 2007

Area of Science:

Developmental Biology
Regenerative Medicine
Stem Cell Biology

Background:

Adult somatic cells can be reprogrammed to a pluripotent state.
This reprogramming is achieved through the forced expression of specific genes.

Observation:

Induced pluripotent stem cells (iPS) resemble embryonic stem cells (ES).
iPS cells differentiate into tissues from all three embryonic germ layers.
iPS cells contribute to complete organism development, including germline, when introduced into early embryos.

Findings:

Demonstration of successful reprogramming of mature cells into iPS cells.
Validation of iPS cell pluripotency and developmental potential.
Identification of key genes (Oct-3/4, c-Myc, Klf4, Sox2) driving reprogramming.

Implications:

Significant advancements in regenerative medicine.
Potential for novel cellular therapies.
Expanded research avenues in developmental biology and stem cell applications.